We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current EMD market cap is 12.47M. The company's latest EPS is AUD -0.0312 and P/E is -0.96.
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 1.48M | 2.93M | 3.09M | 3.8M | 4.82M |
| Operating Income | -5.2M | -4.86M | -7.27M | -4.9M | -11.22M |
| Net Income | -5.24M | -4.91M | -7.33M | -5.13M | -11.46M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 5.07M | 9.06M | 8.25M | 10.16M | 5.43M |
| Total Liabilities | 1.28M | 1.88M | 1.93M | 3.37M | 3M |
| Total Equity | 3.78M | 7.18M | 6.32M | 6.79M | 2.43M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -4.45M | -3.94M | -5.43M | -3.77M | -4.29M |
| Investing | -202k | -661k | -2.03M | -3.23M | -1.38M |
| Financing | 5.73M | 7.44M | 4.81M | 5.86M | 4.5M |
| Market Cap | 12.47M |
| Price to Earnings Ratio | -0.96 |
| Price to Sales Ratio | 2.29 |
| Price to Cash Ratio | 6.98 |
| Price to Book Ratio | 4.54 |
| Dividend Yield | - |
| Shares Outstanding | 366.63M |
| Average Volume (1 week) | 116.41k |
| Average Volume (1 Month) | 371.46k |
| 52 Week Change | -34.62% |
| 52 Week High | 0.076 |
| 52 Week Low | 0.0265 |
| Spread (Intraday) | 0 (5.56%) |
| Company Name | Emyria Limited |
| Address |
d2 661 newcastle street perth, western australia 6007 |
| Website | https://www.emeraldclinics.com.au |
| Industry | med, dental, hosp eq-whsl (5047) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
